HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing.
The increasing prevalence of acquired and transmitted HIV-1 drug resistance is an obstacle to successful antiretroviral therapy (ART) in the low- and middle-income countries (LMICs) hardest hit by the HIV-1 pandemic. Genotypic drug resistance testing could facilitate the choice of initial ART in are...
Saved in:
| Main Authors: | Soo-Yon Rhee, Michael R Jordan, Elliot Raizes, Arlene Chua, Neil Parkin, Rami Kantor, Gert U Van Zyl, Irene Mukui, Mina C Hosseinipour, Lisa M Frenkel, Nicaise Ndembi, Raph L Hamers, Tobias F Rinke de Wit, Carole L Wallis, Ravindra K Gupta, Joseph Fokam, Clement Zeh, Jonathan M Schapiro, Sergio Carmona, David Katzenstein, Michele Tang, Avelin F Aghokeng, Tulio De Oliveira, Annemarie M J Wensing, Joel E Gallant, Mark A Wainberg, Douglas D Richman, Joseph E Fitzgibbon, Marco Schito, Silvia Bertagnolio, Chunfu Yang, Robert W Shafer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0145772 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Developing a priority global research agenda for antimicrobial resistance in the human health sector: protocol for a scoping review
by: Alessandro Cassini, et al.
Published: (2022-06-01) -
Need assessment for HIV drug resistance testing and landscape of current and future technologies in low- and middle-income countries.
by: Neil Parkin, et al.
Published: (2023-01-01) -
Correction: Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study.
by: Seth C Inzaule, et al.
Published: (2017-01-01) -
Recommendations on data sharing in HIV drug resistance research.
by: Seth C Inzaule, et al.
Published: (2023-09-01) -
Standard of prevention for infectious diseases' prevention clinical trials during pandemics: learning lessons for global policies from biomedical HIV prevention clinical trials and a case study of COVID-19
by: Moréniké Oluwátóyìn Foláyan, et al.
Published: (2025-01-01)